Safety worries grow over a Prader-Willi syndrome drug
Published
Records obtained by STAT tie Vykat XR to seven deaths and nearly 100 hospital stays since its approval, though reports like these don't prove the drug was the cause. A former FDA reviewer is asking the agency to pull it. Families should talk with their child's doctor before making any change.
Source: STAT
This is a plain-language summary. Read the original source for full details.